J L Gross1, W F Herblin, K Eidsvoog, R Horlick, S S Brem. Show Affiliations » 1. Du Pont Merck Pharmaceutical Co., Wilmington, DE 19880-0400.
Abstract
Mesh： See more » AnimalsAntineoplastic Agents/therapeutic useBiphenyl Compounds/therapeutic useCell LineDNA Replication/drug effectsFibroblast Growth Factor 2/geneticsFibroblast Growth Factor 2/pharmacologyFibroblast Growth Factor 2/therapeutic useGlioma/geneticsGlioma/pathologyGlioma/therapyHumansImmunoglobulin G/administration & dosageImmunotherapyKineticsMiceMice, NudeNeoplasm TransplantationRatsReceptors, Cell Surface/geneticsReceptors, Cell Surface/metabolismReceptors, Fibroblast Growth FactorRecombinant Proteins/pharmacologyRecombinant Proteins/therapeutic useSubrenal Capsule AssayThymidine/metabolismTransplantation, HeterologousTumor Cells, Cultured
Substances： See more » Antineoplastic AgentsBiphenyl CompoundsImmunoglobulin GReceptors, Cell SurfaceReceptors, Fibroblast Growth FactorRecombinant ProteinsFibroblast Growth Factor 2brequinarThymidine
Year: 1992 PMID： 1319779 DOI： 10.1007/978-3-0348-7001-6_70
Source DB: PubMed Journal: EXS ISSN： 1023-294X